Alprazolam
Alprazolam, probably better known by its trade name Xanax, is a short-acting drug. The drug is used to treat people with anxiety disorders and panic attacks. Alprazolam is the most commonly misused benzodiazepine (the drug's class) in the United States; but the majority of prescribed users do not develop a substance-use disorder. Alprazolam is a prescription drug in the United States.
|  | |
|  | |
| Clinical data | |
|---|---|
| Pronunciation | Alprazolam /ælˈpræzəlæm/ or /ælˈpreɪzəlæm/, Xanax /ˈzænæks/ | 
| Trade names | Xanax, Xanor, Niravam, others | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a684001 | 
| Pregnancy category | |
| Dependence liability | High | 
| Routes of administration | By mouth | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Bioavailability | 80–90% | 
| Protein binding | 80% | 
| Metabolism | Liver, via cytochrome P450 3A4 | 
| Metabolites | alpha-hydroxyalprazolam, 4-hydroxyalprazolam, beta-hydroxyalprazolam | 
| Onset of action | less than an hour[1] | 
| Elimination half-life | Immediate release: 4–6 hours Extended release: 11–16 hours | 
| Duration of action | 6 hours[1] | 
| Excretion | Kidney | 
| Identifiers | |
| IUPAC name 
 | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| ECHA InfoCard | 100.044.849  | 
| Chemical and physical data | |
| Formula | C17H13ClN4 | 
| Molar mass | 308.77 g·mol−1 | 
| 3D model (JSmol) | |
| SMILES 
 | |
| InChI 
 | |
| (verify) | |
Sources
    
- Lilley, Linda Lane; Snyder, Julie S.; Collins, Shelly Rainforth (2016). Pharmacology for Canadian Health Care Practice. Elsevier Health Sciences. p. 329. ISBN 9781771720663.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
